March 24, 2017 9:12 PM ET

Pharmaceuticals

Company Overview of G1 Therapeutics, Inc.

Company Overview

G1 Therapeutics, Inc. researches and develops small molecule therapies to address unmet needs in oncology. It offers programs including G1T28-1, to protect bone marrow and other organs from side effects of chemotherapy treatments and radiation. The company was formerly known as G-Zero Therapeutics Inc. G1 Therapeutics, Inc. was founded in 2008 and is based in Research Triangle Park, North Carolina.

79 T.W. Alexander Drive

4401 Research Commons

Suite 105

Research Triangle Park, NC 27709

United States

Founded in 2008

Phone:

919-213-9835

Fax:

919-741-5830

Key Executives for G1 Therapeutics, Inc.

Chief Executive Officer and Director
Co-Founder, Director, and Scientific and Clinical Advisor
Co-Founder and Scientific and Clinical Advisor
Chief Medical Officer
Age: 57
Chief Business Officer
Age: 55
Compensation as of Fiscal Year 2016.

G1 Therapeutics, Inc. Key Developments

G1 Therapeutics, Inc. Presents at 35th Annual JP Morgan Healthcare Conference, Jan-10-2017 09:00 AM

G1 Therapeutics, Inc. Presents at 35th Annual JP Morgan Healthcare Conference, Jan-10-2017 09:00 AM. Venue: Westin St. Francis Hotel, 335 Powell Street, San Francisco, CA 94102, United States. Speakers: Mark Velleca, Chief Executive Officer and Director.

G1 Therapeutics, Inc. Presents at Wedbush PacGrow Healthcare Conference 2016, Aug-17-2016 01:55 PM

G1 Therapeutics, Inc. Presents at Wedbush PacGrow Healthcare Conference 2016, Aug-17-2016 01:55 PM. Venue: Le Parker Meridien, New York, New York, United States. Speakers: Rajesh K. Malik, Chief Medical Officer.

G1 Therapeutics, Inc. Presents at 18th Annual BIO CEO & Investor Conference 2016, Feb-09-2016 01:30 PM

G1 Therapeutics, Inc. Presents at 18th Annual BIO CEO & Investor Conference 2016, Feb-09-2016 01:30 PM. Venue: The Waldorf Astoria, 301 Park Avenue, New York, New York, United States. Speakers: Mark Velleca, Chief Executive Officer and Director.

Similar Private Companies By Industry

Company Name Region
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States
7 Oaks Pharmaceutical Corp. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
April 27, 2016
--
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact G1 Therapeutics, Inc., please visit www.g1therapeutics.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.